You need to upgrade your Flash Player to view this content.
Latest data on PCSK9 inhibitors from ESC Congress 2014
Slides on ODYSSEY LONG TERM, COMBOS II, & FH I & II of the novel PCSK9 inhibitor, alirocumab, from ESC14.
Case study: clinical application of the ACC/AHA cholesterol guidelines
Join JoAnne Foody, MD, on an interactive journey toward primary prevention in a 48-year-old patient with LDL 150 and elevated ASCVD risk. Login required.
ACC/AHA lifestyle guidelines coverage
Interactive summary recommendations & slides on the ACC/AHA lifestyle guidelines. Slides available for download in the slide library.
Your CVD guidelines resource
Summary recommendations & slides on ACC/AHA cholesterol guidelines, AHA/ACC/TOS obesity guidelines, & more.
Dabigatran (Pradaxa) FDA Drug Safety Communication
Lower risk for stroke and death, but higher risk for GI bleeding, seen with dabigatran vs warfarin among Medicare patients aged 65 or older. FDA has made no changes to Pradaxa labeling or recommendations for use. More here.
Not a member? What are you waiting for?
Sign up now for exclusive access to downloadable slides and other content from CCMDweb.org. Registration is free and takes just a moment to complete.
CCMDweb.org: Professional Education
for Cardiovascular Disease
CCMDweb.org is a premier destination for professional education, clinically relevant information, and programs that augment knowledge and practice gaps in cardiovascular disease (CVD) with the goal of enhancing patient care. Since 1996, CCMD has partnered with preeminent thought leaders to educate US healthcare professionals on issues spanning the cardiovascular disease (CVD) spectrum—highlighting many cardiometabolic conditions that individually or collectively contribute to cardiovascular risk, including dyslipidemia, atherosclerosis, diabetes, stroke, inflammation, and obesity.
A sample of the award-winning programs on CCMDweb.org:
- Slide library with nearly 1,000 downloadable slides exploring cardiometabolic diseases
- On-demand programs, including newsletters, case studies, and webcasts
- Clinical guidelines resources
- Expert commentaries on seminal research
- Patient education handouts
- And more!
Registration is free and unlocks premium content offerings and incentives. Sign up here
CCMDweb.org is the official website of The Committee on Cardiovascular and Metabolic Diseases™ (CCMD™), a multi-component independent educational initiative offering programs and resources focused on the management of cardiovascular and metabolic diseases as a means to prevent or reduce global cardiovascular risk. Click here
for more information about CCMD.